SEAN CAINE: Open Payments
NPI 1689052581 · NEW HYDE PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$579 in 38 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $169 · 2025 $579
Food & beverage: $579
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $157 |
| Novartis Pharmaceuticals Corporation | 5 | $102 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $60 |
| Amgen Inc. | 3 | $60 |
| Merck Sharp & Dohme LLC | 2 | $59 |
| Lilly USA, LLC | 2 | $43 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| Renalytix AI, Inc. | 2 | $39 |
| Novo Nordisk Inc | 1 | $15 |
Products named: ELIQUIS, LEQVIO, XIFAXAN, GARDASIL 9, MOUNJARO, PREVNAR 20, PAXLOVID, OTEZLA.
Industry payments across NY — which companies pay providers there.
